LOADING
Comparing Visa Inc (V) and Thermo Fisher Scientific (TMO) across the Financials and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | V | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $663.7B | $195.9B |
| P/E Ratio | 30.4 | 29.0 |
| Forward P/E | 23.3 | 21.2 |
| PEG Ratio | 1.53 | 1.74 |
| EPS | $11.48 | $18.18 |
| Revenue Growth (YoY) | 17.1% | 6.2% |
| Profit Margin | 51.7% | 15.1% |
| Return on Equity | 60.4% | 13.5% |
| Dividend Yield | 0.75% | 0.34% |
| Beta | 0.75 | 0.87 |
| 52-Week High | $365.02 | $642.71 |
| 52-Week Low | $293.28 | $401.89 |
| Volume | -- | -- |
Visa Inc is the larger company by market capitalization. Thermo Fisher Scientific trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Visa Inc offers a higher dividend yield for income investors. Visa Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.